Our Strategy is designed to leverage our portfolio and capabilities and has four key elements;
- Drive portfolio growth by increasing household penetration
- Capitalise on new and emerging growth opportunities through channel, geographic and portfolio expansion.
- Underpin performance with strong execution and financial discipline
- Running a responsible business
Haleon has grown through two large M&A transactions (Novartis JV in 2015 with a buy-out in 2018 and Pfizer JV in 2019) and a series of brand divestments to build a focused consumer healthcare portfolio with category leading positions.